PT  - JOURNAL ARTICLE
AU  - Taha, Anas
AU  - Taha-Mehlitz, Stephanie
AU  - Ochs, Vincent
AU  - Enodien, Bassey
AU  - Honaker, Michael Drew
AU  - Frey, Daniel M.
AU  - Cattin, Philippe C.
TI  - Developing and validating a multivariable prediction model for predicting costs of colon surgery
AID  - 10.1101/2022.02.02.22270329
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.02.02.22270329
4099  - http://medrxiv.org/content/early/2022/09/26/2022.02.02.22270329.short
4100  - http://medrxiv.org/content/early/2022/09/26/2022.02.02.22270329.full
AB  - Hospitals are burdened with predicting, calculating and managing various cost-affecting parameters regarding patients and their treatments. Accuracy in cost prediction is further affected if a patient suffers from other health issues which hinder the traditional prognosis. This can lead to an unavoidable deficit in the final revenue of medical centers. This study aims to determine whether machine learning (ML) algorithms can predict cost factors based on patients undergoing colon surgery. For the forecasting, multiple predictors will be taken into the model to provide a tool that can be helpful for hospitals to manage their costs which ultimately will lead to operating more cost-efficiently.. This proof of principle will lay the groundwork for an efficient ML-based prediction tool based on multicenter data from a range of international centers in the subsequent phases of the study. With a % MAPE result of 18 – 25.6, our model’s prediction showed decent results to forecast the costs regarding various diagnosed factors and surgical approaches. There is an urgent need for further studies on predicting cost factors, especially for cases with anastomotic leakage, to minimize unnecessary costs for hospitals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding Ethics: Cantonal Ethics Committee Zurich, Switzerland BASEC Nr. 2021-01107Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Cantonal Ethics Committee Zurich, Switzerland BASEC Nr. 2021-01107I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors